|
1
|
MacFarlane M: TRAIL-induced signalling and
apoptosis. Toxicol Lett. 139:89–97. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pan G, Ni J, Wei YF, Yu G, Gentz R and
Dixit VM: An antagonist decoy receptor and a death
domain-containing receptor for TRAIL. Science. 277:815–818. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Emery JG, McDonnell P, Burke MB, et al:
Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. J
Biol Chem. 273:14363–14367. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mellier G, Huang S, Shenoy K and Pervaiz
S: TRAILing death in cancer. Mol Aspects Med. 31:93–112. 2010.
View Article : Google Scholar
|
|
5
|
Zhang L and Fang B: Mechanisms of
resistance to TRAIL-induced apoptosis in cancer. Cancer Gene Ther.
12:228–237. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rieger J, Frank B, Weller M and Wick W:
Mechanisms of resistance of human glioma cells to Apo2
ligand/TNF-related apoptosis-inducing ligand. Cell Physiol Biochem.
20:23–34. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kurbanov BM, Fecker LF, Geilen CC, Sterry
W and Eberle J: Resistance of melanoma cells to TRAIL does not
result from upregulation of antiapoptotic proteins by NF-kappaB but
is related to downregulation of initiator caspases and DR4.
Oncogene. 26:3364–3377. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jung EM, Lim JH, Lee TJ, Park JW, Choi KS
and Kwon TK: Curcumin sensitizes tumor necrosis factor-related
apoptosis-inducing ligand (TRAIL)-induced apoptosis through
reactive oxygen species-mediated upregulation of death receptor 5
(DR5). Carcinogenesis. 26:1905–1913. 2005. View Article : Google Scholar
|
|
9
|
Prasad S, Ravindran J, Sung B, Pandey MK
and Aggarwal BB: Garcinol potentiates TRAIL-induced apoptosis
through modulation of death receptors and antiapoptotic proteins.
Mol Cancer Ther. 9:856–868. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sung B, Ravindran J, Prasad S, Pandey MK
and Aggarwal BB: Gossypol induces death receptor-5 through
activation of the ROS-ERK-CHOP pathway and sensitizes colon cancer
cells to TRAIL. J Biol Chem. 285:35418–35427. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Siegelin MD, Reuss DE, Habel A,
Herold-Mende C and von Deimling A: The flavonoid kaempferol
sensitizes human glioma cells to TRAIL-mediated apoptosis by
proteasomal degradation of survivin. Mol Cancer Ther. 7:3566–3574.
2008. View Article : Google Scholar
|
|
12
|
Koh DJ, Ahn HS, Chung HS, et al:
Inhibitory effects of casticin on migration of eosinophil and
expression of chemokines and adhesion molecules in A549 lung
epithelial cells via NF-kappaB inactivation. J Ethnopharmacol.
136:399–405. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Choudhary MI, Jalil S, Nawaz SA, Khan KM
and Tareen RB: Antiinflammatory and lipoxygenase inhibitory
compounds from Vitex agnus-castus. Phytother Res.
23:1336–1339. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mesaik MA, Murad S, Khan KM, Tareen RB,
Ahmed A and Choudhary MI: Isolation and immunomodulatory properties
of a flavonoid, casticin from Vitex agnus-castus. Phytother
Res. 23:1516–1520. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Csupor-Loffler B, Hajdu Z, Zupko I, et al:
Antiproliferative effect of flavonoids and sesquiterpenoids from
Achillea millefolium sl on cultured human tumour cell lines.
Phytother Res. 23:672–676. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Haidara K, Zamir L, Shi QW and Batist G:
The flavonoid Casticin has multiple mechanisms of tumor
cytotoxicity action. Cancer Lett. 242:180–190. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kobayakawa J, Sato-Nishimori F, Moriyasu M
and Matsukawa Y: G2-M arrest and antimitotic activity mediated by
casticin, a flavonoid isolated from Viticis Fructus
(Vitex rotundifolia Linne file). Cancer Lett. 208:59–64.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shen JK, Du HP, Yang M, Wang YG and Jin J:
Casticin induces leukemic cell death through apoptosis and mitotic
catastrophe. Ann Hematol. 88:743–752. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang J, Yang Y, Tian L, Sheng XF, Liu F
and Cao JG: Casticin-induced apoptosis involves death receptor 5
upregulation in hepatocellular carcinoma cells. World J
Gastroenterol. 17:4298–4307. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cao JG, Peng SP, Sun L, Li H, Wang L and
Deng HW: Vascular basement membrane-derived multifunctional
peptide, a novel inhibitor of angiogenesis and tumor growth. Acta
Biochim Biophys Sin. 38:514–521. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang XH, Zheng X, Cao JG, Xiang HL, Liu F
and Lv Y: 8-Bromo-7-methoxychrysin-induced apoptosis of
hepatocellular carcinoma cells involves ROS and JNK. World J
Gastroenterol. 16:3385–3393. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fulda S, Meyer E and Debatin KM:
Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression.
Oncogene. 21:2283–2294. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Song JJ, An JY, Kwon YT and Lee YJ:
Evidence for two modes of development of acquired tumor necrosis
factor-related apoptosis-inducing ligand resistance. Involvement of
Bcl-xL. J Biol Chem. 282:319–328. 2007. View Article : Google Scholar
|
|
24
|
Azuhata T, Scott D, Griffith TS, Miller M
and Sandler AD: Survivin inhibits apoptosis induced by TRAIL, and
the ratio between survivin and TRAIL receptors is predictive of
recurrent disease in neuroblastoma. J Pediatr Surg. 41:1431–1440.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Siegelin MD, Gaiser T and Siegelin Y: The
XIAP inhibitor Embelin enhances TRAIL-mediated apoptosis in
malignant glioma cells by down-regulation of the short isoform of
FLIP. Neurochem Int. 55:423–430. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kwon D, Choi K, Choi C and Benveniste EN:
Hydrogen peroxide enhances TRAIL-induced cell death through
up-regulation of DR5 in human astrocytic cells. Biochem Biophys Res
Commun. 372:870–874. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yodkeeree S, Sung B, Limtrakul P and
Aggarwal BB: Zerumbone enhances TRAIL-induced apoptosis through the
induction of death receptors in human colon cancer cells: evidence
for an essential role of reactive oxygen species. Cancer Res.
69:6581–6589. 2009. View Article : Google Scholar
|
|
28
|
Ola MS, Nawaz M and Ahsan H: Role of Bcl-2
family proteins and caspases in the regulation of apoptosis. Mol
Cell Biochem. 351:41–58. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Altieri DC: Survivin and IAP proteins in
cell-death mechanisms. Biochem J. 430:199–205. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Safa AR and Pollok KE: Targeting the
anti-apoptotic protein c-FLIP for cancer therapy. Cancers.
3:1639–1671. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bradley JR and Pober JS: Tumor necrosis
factor receptor-associated factors (TRAFs). Oncogene. 20:6482–6491.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kim H, Kim EH, Eom YW, et al: Sulforaphane
sensitizes tumor necrosis factor-related apoptosis-inducing ligand
(TRAIL)-resistant hepatoma cells to TRAIL-induced apoptosis through
reactive oxygen species-mediated up-regulation of DR5. Cancer Res.
66:1740–1750. 2006. View Article : Google Scholar
|
